AMLX
Price
$12.42
Change
+$0.09 (+0.73%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
1.36B
138 days until earnings call
Intraday BUY SELL Signals
SVRA
Price
$4.26
Change
+$0.14 (+3.40%)
Updated
Nov 13 closing price
Capitalization
866.77M
132 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMLX vs SVRA

Header iconAMLX vs SVRA Comparison
Open Charts AMLX vs SVRABanner chart's image
Amylyx Pharmaceuticals
Price$12.42
Change+$0.09 (+0.73%)
Volume$7.63K
Capitalization1.36B
Savara
Price$4.26
Change+$0.14 (+3.40%)
Volume$3.88M
Capitalization866.77M
AMLX vs SVRA Comparison Chart in %
AMLX
Daily Signal:
Gain/Loss:
SVRA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AMLX vs. SVRA commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and SVRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (AMLX: $12.33 vs. SVRA: $4.12)
Brand notoriety: AMLX and SVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 68% vs. SVRA: 136%
Market capitalization -- AMLX: $1.36B vs. SVRA: $866.77M
AMLX [@Biotechnology] is valued at $1.36B. SVRA’s [@Biotechnology] market capitalization is $866.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileSVRA’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • SVRA’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than SVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 5 TA indicator(s) are bullish while SVRA’s TA Score has 3 bullish TA indicator(s).

  • AMLX’s TA Score: 5 bullish, 5 bearish.
  • SVRA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than SVRA.

Price Growth

AMLX (@Biotechnology) experienced а -6.87% price change this week, while SVRA (@Biotechnology) price change was +2.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

AMLX is expected to report earnings on Apr 01, 2026.

SVRA is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($1.36B) has a higher market cap than SVRA($867M). AMLX YTD gains are higher at: 226.190 vs. SVRA (34.202). SVRA has higher annual earnings (EBITDA): -116.49M vs. AMLX (-196.3M). AMLX has more cash in the bank: 181M vs. SVRA (146M). AMLX has less debt than SVRA: AMLX (5.96M) vs SVRA (29.7M). SVRA has higher revenues than AMLX: SVRA (0) vs AMLX (-249K).
AMLXSVRAAMLX / SVRA
Capitalization1.36B867M157%
EBITDA-196.3M-116.49M169%
Gain YTD226.19034.202661%
P/E Ratio2.69N/A-
Revenue-249K0-
Total Cash181M146M124%
Total Debt5.96M29.7M20%
FUNDAMENTALS RATINGS
SVRA: Fundamental Ratings
SVRA
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
52
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXSVRA
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signal:
Gain/Loss:
SVRA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MECAX49.750.28
+0.57%
AMG GW&K International Small Cap N
FCIKX17.860.09
+0.51%
NYLI PineStone International Eq Inv Cl
TSFAX14.470.05
+0.35%
Touchstone Small Cap A
FCCVX39.63N/A
N/A
Fidelity Advisor Convertible Secs C
FIKZX22.93N/A
N/A
Fidelity Advisor Asset Manager 50% Z

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-2.76%
XOMAO - AMLX
68%
Closely correlated
+0.08%
XOMAP - AMLX
51%
Loosely correlated
-0.18%
OCUL - AMLX
49%
Loosely correlated
+2.41%
RGNX - AMLX
45%
Loosely correlated
+0.43%
IPSC - AMLX
44%
Loosely correlated
N/A
More

SVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with RCKT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
-4.85%
RCKT - SVRA
58%
Loosely correlated
+1.23%
PRTA - SVRA
46%
Loosely correlated
+3.53%
OCUL - SVRA
40%
Loosely correlated
+2.41%
AMLX - SVRA
39%
Loosely correlated
-2.76%
RGNX - SVRA
37%
Loosely correlated
+0.43%
More